Moderna
Modernas stock price skyrocketed as much as 30 on monday after the biotech company announced promising early results for its coronavirus vaccine.
Moderna. Moderna therapeutics is pioneering a new class of drugs messenger rna therapeutics with the vast potential to treat many diseases across a range of drug modalities and therapeutic areas. During a recent conference call to discuss. Moderna is making changes to the trial plan called a protocol which has pushed back the expected start date of the phase 3 study according to investigators. Moderna stock tumbled monday after an analyst suggested the coronavirus vaccine maker is overvalued.
Until recently moderna was best known although not really well known for another mrna vaccine. The moderna technology platform is to insert synthetic mrna into living cells that would reprogram the cells to develop immune responses rather than being created externally and injected. It is headquartered in cambridge massachusetts. Moderna was by far the smallest of the seven drugmakers in this meeting.
We believe mrna is the software of life every cell in the body uses mrna to provide real time instructions to make the proteins necessary to drive all aspects of biology including in human health and disease. Moderna is an american biotechnology company focused on drug discovery drug development and vaccine technologies based exclusively on messenger rna mrna. The investigators who spoke on. As ordinary investors piled in two insiders.
Jpmorgan chase analyst cory kasimov acknowledged modernas rapid development of a. Modernas vaccine is the first to be tested in the u.